MedPath
NMPA Approval

Tafluprost Eye Drops

国药准字HJ20150528

August 5, 2024

H20150528

Drug Information

他氟前列素滴眼液

泰普罗斯

滴眼剂

0.0015%(2.5ml:37.5μg)

化学药品

August 5, 2024

August 4, 2029

Company Information

Applicant Company

4-20 Ofuka-cho, Kita-ku, Osaka, Japan

Manufacturing Company

santen pharmaceutical co.,ltd. shiga plant

348-3, Aza-suwa, Oaza-shide, Taga-cho, Inukami-gun, Shiga, Japan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

他氟前列素滴眼液 - NMPA 批准文号 | MedPath